AG
Highly rated in
19
conditions
Highly rated in
19
conditions
Check Dr. Audrey M. Garrett's experience treating your condition:
About Dr. Audrey M. Garrett

Audrey Garrett is a Hematologist Oncology expert in Brewer, Maine. Garrett has been practicing medicine for over 33 years and is highly rated in 19 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Bone Marrow Aspiration. She is licensed to treat patients in Maine. Garrett is currently accepting new patients.

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 2 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Audrey M. Garrett it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Audrey M. Garrett accepts the following insurance:

  •  Ambetter
  •  Anthem
Locations
33 Whiting Hill Rd, Suite 21, Brewer, ME 04412
Background & Education
Graduate Institution
Boston University School Of Medicine, 1989
Specialties
Hematology Oncology
Licenses
Internal Medicine in ME
Hospital Affiliations
Down East Community Hospital
Calais Community Hospital
Northern Light Inland Hospital
Millinocket Regional Hospital
Waldo County General Hospital
Houlton Regional Hospital
Northern Light Sebasticook Valley Hospital
Northern Light CA Dean Hospital
Penobscot Valley Hospital
Northern Light Mayo Hospital
Northern Light Blue Hill Hospital
Northern Light AR Gould Hospital
St Joseph Hospital Of ME
Northern Light Maine Coast Hospital
Northern Light Eastern Maine Medical Center
Languages Spoken
English
French
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors